Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018 (2018), Article ID 7616852, 13 pages
https://doi.org/10.1155/2018/7616852
Research Article

Ingredients from Litsea garrettii as Potential Preventive Agents against Oxidative Insult and Inflammatory Response

1Key Lab of Chemical Biology (MOE), School of Pharmaceutical Sciences, Shandong University, 44 Wenhua Xi Road, Jinan 250012, China
2Department of Pharmacy, Jinan Maternity and Child Care Hospital, Jianguo Xiaojingsan Road, Jinan 250000, China

Correspondence should be addressed to Tao Shen; nc.ude.uds@oatnehs

Received 21 September 2017; Revised 19 December 2017; Accepted 9 January 2018; Published 20 March 2018

Academic Editor: Roberto Mattioli

Copyright © 2018 Yan-Ru Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Bargagli, C. Olivieri, D. Bennett, A. Prasse, J. Muller-Quernheim, and P. Rottoli, “Oxidative stress in the pathogenesis of diffuse lung diseases: a review,” Respiratory Medicine, vol. 103, no. 9, pp. 1245–1256, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Li and M. Karin, “Is NF-κB the sensor of oxidative stress?” The FASEB Journal, vol. 13, no. 10, pp. 1137–1143, 1999. View at Publisher · View at Google Scholar
  3. S. Reuter, S. C. Gupta, M. M. Chaturvedi, and B. B. Aggarwal, “Oxidative stress, inflammation, and cancer: how are they linked?” Free Radical Biology & Medicine, vol. 49, no. 11, pp. 1603–1616, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Khansari, Y. Shakiba, and M. Mahmoudi, “Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer,” Recent Patents on Inflammation Allergy Drug Discovery, vol. 3, no. 1, pp. 73–80, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. C. P. Domingueti, L. M. S. Dusse, M. das Graças Carvalho, L. P. de Sousa, K. B. Gomes, and A. P. Fernandes, “Diabetes mellitus: the linkage between oxidative stress, inflammation, hypercoagulability and vascular complications,” Journal of Diabetes and its Complications, vol. 30, no. 4, pp. 738–745, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Stanojkovic, J. Kotur-Stevuljevic, B. Milenkovic et al., “Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation,” Respiratory Medicine, vol. 105, pp. S31–S37, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Agostinho, R. A. Cunha, and C. Oliveira, “Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease,” Current Pharmaceutical Design, vol. 16, no. 25, pp. 2766–2778, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Menegon, A. Columbano, and S. Giordano, “The dual roles of Nrf2 in cancer,” Trends in Molecular Medicine, vol. 22, no. 7, pp. 578–593, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Lau, N. Villeneuve, Z. Sun, P. Wong, and D. Zhang, “Dual roles of Nrf2 in cancer,” Pharmacological Research, vol. 58, no. 5-6, pp. 262–270, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. M. C. Jaramillo and D. D. Zhang, “The emerging role of the Nrf2-Keap1 signaling pathway in cancer,” Genes Development, vol. 27, no. 20, pp. 2179–2191, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Milkovic, N. Zarkovic, and L. Saso, “Controversy about pharmacological modulation of Nrf2 for cancer therapy,” Redox Biology, vol. 12, pp. 727–732, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Lawrence, “The nuclear factor NF-κB pathway in inflammation,” Cold Spring Harbor Perspectives in Biology, vol. 1, no. 6, article a001651, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. Y.-J. Surh and H.-K. Na, “NF-κB and Nrf2 as prime molecular targets for chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals,” Genes & Nutrition, vol. 2, no. 4, pp. 313–317, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. P. P. Tak and G. S. Firestein, “NF-κB: a key role in inflammatory diseases,” The Journal of Clinical Investigation, vol. 107, no. 1, pp. 7–11, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Shen, T. Jiang, M. Long et al., “A curcumin derivative that inhibits vinyl carbamate-induced lung carcinogenesis via activation of the Nrf2 protective response,” Antioxidants & Redox Signaling, vol. 23, no. 8, pp. 651–664, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Shen, X.-M. Chen, B. Harder et al., “Plant extracts of the family Lauraceae: a potential resource for chemopreventive agents that activate the nuclear factor-erythroid 2-related factor 2/antioxidant response element pathway,” Planta Medica, vol. 80, no. 5, pp. 426–434, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. M.-X. Zhou, X. Wei, A.-L. Li et al., “Screening of traditional Chinese medicines with therapeutic potential on chronic obstructive pulmonary disease through inhibiting oxidative stress and inflammatory response,” BMC Complementary and Alternative Medicine, vol. 16, no. 1, p. 360, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Chen and M. Gilbert, Flora of China, Science and Missouri Botanical Garden Press, Beijing and St Louis, 2006.
  19. J. Wang, D. Sun, W. Lv, J. Li, M. Zhao, and S. Zhang, “Chemical constituents from fallen leaves of Populus alba,” Zhong Cao Yao, vol. 44, no. 23, pp. 3276–3281, 2013. View at Google Scholar
  20. J. Fang, H. Duan, Y. Zhang, and T. Yoshihisa, “Chemical constituents from herb of Alternanthera philoxeroides,” Zhongguo Zhong Yao Za Zhi, vol. 31, no. 13, pp. 1072–1075, 2009. View at Google Scholar
  21. Z. Zhu, L. Ma, H. Zhu, X. Yang, and X. Hao, “Studies on the chemical constituents of Laportea bulbifera,” Zhong Yao Cai, vol. 34, no. 2, pp. 223–225, 2011. View at Google Scholar
  22. C. Kihampa, M. H. H. Nkunya, C. C. Joseph et al., “Anti-mosquito and antimicrobial nor-halimanoids, isocoumarins and an anilinoid from Tessmannia densiflora,” Phytochemistry, vol. 70, no. 10, pp. 1233–1238, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. P.-C. Lin, S. Li, S.-J. Wang, Y.-C. Yang, and J.-G. Shi, “Phenolic constituents in Embelia ribes,” Zhong Cao Yao, vol. 37, no. 6, p. 818, 2006. View at Google Scholar
  24. J. Yuan, Z. Zou, X. Yang et al., “Chemical constituents from seeds of Caesalpinia minax Hance,” Yaowu Fenxi Zazhi, vol. 28, no. 9, pp. 1489–1493, 2008. View at Google Scholar
  25. J. Feng, X. Yang, S. Su, and C. He, “Studies on chemical constituents from herbs of Usnea longissima,” Zhongguo Zhong Yao Za Zhi, vol. 34, no. 6, pp. 708–711, 2009. View at Google Scholar
  26. K. Keisuke, S. Purevsuren, S. Narantuya et al., “Alkaloids from Oxytropis myriophylla (Pall) DC,” Scientia Pharmaceutica, vol. 69, no. 4, pp. 383–388, 2001. View at Publisher · View at Google Scholar
  27. S. Smith, “VII.-Nor-d-ψ-ephedrine, an alkaloid from Ephedra species,” Journal of the Chemical Society, vol. 0, no. 0, pp. 51–53, 1928. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Taguchi and M. Kojima, “Study in stereochemistry. I.: alkanolamines.(1).: action of methylating agents on dl-trans-2, 5-diphenyl-4-methyloxazoline,” Pharmaceutical Bulletin, vol. 1, no. 4, pp. 325–328, 1953. View at Publisher · View at Google Scholar
  29. Y. Jiang, H. Li, X. Pan, X. Sun, Q. Tang, and M. Shao, “Chemical constituents from the roots of Ilex pubescens,” Zhong Yao Cai, vol. 36, no. 11, pp. 1774–1778, 2013. View at Google Scholar
  30. J. Tan, P. Bednarek, J. Liu, B. Schneider, A. Svatoš, and K. Hahlbrock, “Universally occurring phenylpropanoid and species-specific indolic metabolites in infected and uninfected Arabidopsis thaliana roots and leaves,” Phytochemistry, vol. 65, no. 6, pp. 691–699, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Guo and J. Li, “Study on flavonoids of Cuscuta australis R. Br,” Zhongguo Zhong Yao Za Zhi, vol. 22, no. 1, pp. 38-39, 1997. View at Google Scholar
  32. J. He, J. Xian, Y. Song, and S. Song, “Chemical constituents of the root of Ampelopsis japonica (Thunb.) Makino,” Journal of Shenyang Pharmaceutical University, vol. 25, no. 8, pp. 636–638, 2008. View at Google Scholar
  33. W. Zheng, Y. Zhong, J. Sun, and P. Zhang, “Study on the chemical constituents of Orostachys fimbriatus (Turcz.) Berger,” Zhong Cao Yao, vol. 40, no. 6, pp. 859–862, 2009. View at Google Scholar
  34. A. Lau, S. A. Whitman, M. C. Jaramillo, and D. D. Zhang, “Arsenic-mediated activation of the Nrf2-Keap1 antioxidant pathway,” Journal of Biochemical and Molecular Toxicology, vol. 27, no. 2, pp. 99–105, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Korhonen, A. Lahti, H. Kankaanranta, and E. Moilanen, “Nitric oxide production and signaling in inflammation,” Current Drug Targets-Inflammation Allergy, vol. 4, no. 4, pp. 471–479, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. L.-L. Ji, Y.-C. Sheng, Z.-Y. Zheng, L. Shi, and Z.-T. Wang, “The involvement of p62-Keap1-Nrf2 antioxidative signaling pathway and JNK in the protection of natural flavonoid quercetin against hepatotoxicity,” Free Radical Biology & Medicine, vol. 85, pp. 12–23, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Tanigawa, M. Fujii, and D. Hou, “Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin,” Free Radical Biology & Medicine, vol. 42, no. 11, pp. 1690–1703, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. C. L. L. Saw, Y. Guo, A. Y. Yang et al., “The berry constituents quercetin, kaempferol, and pterostilbene synergistically attenuate reactive oxygen species: involvement of the Nrf2-ARE signaling pathway,” Food and Chemical Toxicology, vol. 72, pp. 303–311, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Hämäläinen, R. Nieminen, P. Vuorela, M. Heinonen, and E. Moilanen, “Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-κB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-κB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages,” Mediators of Inflammation, vol. 2007, Article ID 45673, 10 pages, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. E. M. Glenn, B. J. Bowman, and N. A. Rohloff, “Anomalous biological effects of salicylates and prostaglandins,” Inflammation Research, vol. 9, no. 3, pp. 257–264, 1979. View at Google Scholar
  41. S. K. Oettl, J. Gerstmeier, S. Y. Khan et al., “Imbricaric acid and perlatolic acid: multi-targeting anti-inflammatory depsides from Cetrelia monachorum,” PLoS One, vol. 8, no. 10, article e76929, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. P. H. Dang, H. X. Nguyen, N. T. Nguyen, H. N. T. Le, and M. T. T. Nguyen, “α-Glucosidase inhibitors from the stems of Embelia ribes,” Phytotherapy Research, vol. 28, no. 11, pp. 1632–1636, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. C.-P. Chang, H.-S. Chang, C.-F. Peng, S.-J. Lee, and I.-S. Chen, “Antitubercular resorcinol analogs and benzenoid C-glucoside from the roots of Ardisia cornudentata,” Planta Medica, vol. 77, no. 01, pp. 60–65, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Sinha, J. Biswas, and A. Bishayee, “Nrf2-Mediated redox signaling in arsenic carcinogenesis: a review,” Archives of Toxicology, vol. 87, no. 2, pp. 383–396, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. Q. Ma, “Role of Nrf2 in oxidative stress and toxicity,” Annual Review of Pharmacology and Toxicology, vol. 53, no. 1, pp. 401–426, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. W. Ding, L. G. Hudson, and K. J. Liu, “Inorganic arsenic compounds cause oxidative damage to DNA and protein by inducing ROS and RNS generation in human keratinocytes,” Molecular and Cellular Biochemistry, vol. 279, no. 1-2, pp. 105–112, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Shi, X. Shi, and K. J. Liu, “Oxidative mechanism of arsenic toxicity and carcinogenesis,” Molecular and Cellular Biochemistry, vol. 255, no. 1/2, pp. 67–78, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Cai, G. Qiu, X. Gong, Y. Chen, and H. Zhao, “Effects of erythromycin on γ-glutamyl cysteine synthetase and interleukin-1β in hyperoxia-exposed lung tissue of premature newborn rats,” Jornal de Pediatria, vol. 90, no. 5, pp. 493–499, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Zou, D. Feng, W.-H. Ling, and R.-D. Duan, “Lycopene suppresses proinflammatory response in lipopolysaccharide-stimulated macrophages by inhibiting ROS-induced trafficking of TLR4 to lipid raft-like domains,” The Journal of Nutritional Biochemistry, vol. 24, no. 6, pp. 1117–1122, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. B. Tian, D. E. Nowak, M. Jamaluddin, S. Wang, and A. R. Brasier, “Identification of direct genomic targets downstream of the nuclear factor-κB transcription factor mediating tumor necrosis factor signaling,” Journal of Biological Chemistry, vol. 280, no. 17, pp. 17435–17448, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. Sakaguchi, H. Shirahase, A. Ichikawa, M. Kanda, Y. Nozaki, and Y. Uehara, “Effects of selective iNOS inhibition on type II collagen-induced arthritis in mice,” Life Sciences, vol. 75, no. 19, pp. 2257–2267, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Jarvinen, K. Vuolteenaho, R. Nieminen, T. Moilanen, R. Knowles, and E. Moilanen, “Selective iNOS inhibitor 1400W enhances anti-catabolic IL-10 and reduces destructive MMP-10 in OA cartilage. Survey of the effects of 1400W on inflammatory mediators produced by OA cartilage as detected by protein antibody array,” Clinical and Experimental Rheumatology, vol. 26, no. 2, pp. 275–282, 2008. View at Google Scholar
  53. M. Nakanishi and D. W. Rosenberg, “Multifaceted roles of PGE2 in inflammation and cancer,” Seminars in Immunopathology, vol. 35, no. 2, pp. 123–137, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. N. Rajapakse, M. M. Kim, E. Mendis, and S. K. Kim, “Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 in lipopolysaccharide-stimulated RAW 264. 7 cells by carboxybutyrylated glucosamine takes place via down-regulation of mitogen-activated protein kinase-mediated nuclear factor-κB signaling,” Immunology, vol. 123, no. 3, pp. 348–357, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Kuwano, S. NAKAO, H. Yamamoto et al., “Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis,” The FASEB Journal, vol. 18, no. 2, pp. 300–310, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. M. K. McCoy, K. A. Ruhn, A. Blesch, and M. G. Tansey, “TNF: a key neuroinflammatory mediator of neurotoxicity and neurodegeneration in models of Parkinson’s disease,” Advances in TNF Family Research, vol. 691, pp. 539-540, 2011. View at Publisher · View at Google Scholar · View at Scopus